Renaissance Technologies’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.06M | Buy |
384,900
+206,900
| +116% | +$2.72M | 0.01% | 1522 |
|
|
2025
Q1 | $2.56M | Sell |
178,000
-600
| -0.3% | -$8.63K | ﹤0.01% | 1847 |
|
|
2024
Q4 | $2.99M | Sell |
178,600
-31,000
| -15% | -$519K | ﹤0.01% | 1780 |
|
|
2024
Q3 | $3.35M | Buy |
209,600
+35,900
| +21% | +$574K | 0.01% | 1699 |
|
|
2024
Q2 | $1.57M | Sell |
173,700
-45,100
| -21% | -$407K | ﹤0.01% | 2028 |
|
|
2024
Q1 | $2.47M | Buy |
218,800
+33,200
| +18% | +$375K | ﹤0.01% | 1891 |
|
|
2023
Q4 | $1.48M | Buy |
185,600
+132,500
| +250% | +$1.05M | ﹤0.01% | 2147 |
|
|
2023
Q3 | $344K | Buy |
53,100
+18,800
| +55% | +$122K | ﹤0.01% | 2869 |
|
|
2023
Q2 | $212K | Buy |
34,300
+18,600
| +118% | +$115K | ﹤0.01% | 3281 |
|
|
2023
Q1 | $60K | Buy |
+15,700
| New | +$60K | ﹤0.01% | 3616 |
|